scispace - formally typeset
D

Daniel Prieto-Alhambra

Researcher at University of Oxford

Publications -  438
Citations -  11189

Daniel Prieto-Alhambra is an academic researcher from University of Oxford. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 45, co-authored 345 publications receiving 7269 citations. Previous affiliations of Daniel Prieto-Alhambra include Erasmus University Medical Center & Mount Vernon Hospital.

Papers
More filters
Journal Article

Validation of cancer diagnoses in electronic health Records in Catalonia: Preliminary results from the information system for research in primary care (SIDIAP)

Martina Recalde, +10 more
- 01 Jan 2019 - 
Journal ArticleDOI

Oral Bisphosphonate use Reduces Cardiovascular Events in a Cohort of Danish Patients Referred for Bone Mineral Density.

Alexander J. Rodríguez, +10 more
- 01 Oct 2020 - 
TL;DR: Oral BP users experienced a 33% reduced risk of CV events and this observational real-world study adds to a growing body of evidence for cardio-protection by oBP that warrants testing in a randomized setting.
Journal ArticleDOI

Prevalence of vertebral fracture and densitometric osteoporosis in Spanish adult men: The Camargo Cohort Study

José M. Olmos, +10 more
- 01 Jan 2018 - 
TL;DR: The prevalence of osteoporosis in Spanish men using the WHO definition is too small to have any meaningful clinical use, and it would seem that population-based studies of BMD in men are of questionable value.
Journal Article

Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment

Bo Abrahamsen, +3 more
- 29 Jun 2017 - 
Journal ArticleDOI

CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss.

Maria Rodriguez-Sanz, +9 more
- 01 Aug 2015 - 
TL;DR: The genetic association of CYP11A1 gene with AIBL and its expression in bone tissue reveals a potential local function of this enzyme in bone metabolism regulation, offering a new vision of the steroidogenic ability of this tissue and new understanding of AI-induced bone loss.